Current role of selective internal irradiation with yttrium-90 microspheres in the management of hepatocellular carcinoma: A systematic review

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 2, 2011, Pages 460-467

  Lau, Wan Yee ^a   Lai, Eric C H ^a   Leung, Thomas W T ^b  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

Author keywords

Hepatocellular carcinoma; Liver neoplasms; radiotherapy; Selective internal irradiation; Yttrium 90

Indexed keywords

IRRADIATION; LIVER; MICROSPHERES; RADIOTHERAPY; TUMORS; YTTRIUM;

HEPATOCELLULAR CARCINOMA; INTERNAL IRRADIATION; LIVER NEOPLASMS; LIVER TRANSPLANTATION; METHODS AND MATERIALS; PORTAL VEIN INVASIONS; THERAPEUTIC EMBOLIZATION; YTTRIUM-90;

TRANSPLANTATION (SURGICAL);

MACROSALB TC 99M; MICROSPHERE; RESIN; YTTRIUM 90;

ARTIFICIAL EMBOLISM; BILE DUCT OBSTRUCTION; BILIARY TRACT DISEASE; BILOMA; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CHOLECYSTITIS; COMORBIDITY; DRUG SAFETY; FATIGUE; HUMAN; INOPERABLE CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER DYSFUNCTION; LIVER FAILURE; LIVER FIBROSIS; LIVER TRANSPLANTATION; NAUSEA; PORTAL HYPERTENSION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION SICKNESS; REVIEW; SALVAGE THERAPY; SELECTIVE INTERNAL IRRADIATION; SIDE EFFECT; SYSTEMATIC REVIEW;

EID: 80052800154     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.06.010     Document Type: Article

References (77)

1. W.Y. Lau L.H. Blumgart, Y. Fong, Surgery of the liver and biliary tract 2nd ed Primary hepatocellular carcinoma Volume II 2000 W.B. Saunders London 1423 1450
2. W.Y. Lau, and E.C. Lai Hepatocellular carcinoma: Current management and recent advances Hepatobiliary Pancreat Dis Int 7 2008 237 257 (Pubitemid 351895383)
3. E.C. Lai, W.Y. Lau, and D.V. Mann Selection of patients for liver resection W.Y. Lau, Hepatocellular carcinoma 2008 World Scientific Singapore 303 316
4. W.Y. Lau, and E.C. Lai The current role of radiofrequency ablation in the management of hepatocellular carcinoma: A systematic review Ann Surg 249 2009 20 25
5. W.Y. Lau, and E.C. Lai Regional therapy W.Y. Lau, Hepatocellular carcinoma 2008 World Scientific Singapore 661 694
6. W.Y. Lau, S.C. Yu, and E.C. Lai Transarterial chemoembolization for hepatocellular carcinoma J Am Coll Surg 202 2006 155 168 (Pubitemid 41831485)
7. W.Y. Lau Radiotherapy with emphasis on radio-embolization for liver tumours L.H. Blumgart, Y. Fong, Surgery of the liver and biliary tract, Volume II. 2nd ed 2000 W.B. Saunders London 1545 1564
8. E. Ben-Josef, D. Normolle, and W.D. Ensminger Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies J Clin Oncol 23 2005 8739 8747 (Pubitemid 46211519)
9. S. Krishnan, L.A. Dawson, and J. Seong Radiotherapy for hepatocellular carcinoma: An overview Ann Surg Oncol 15 2008 1015 1024
10. L.A. Dawson Hepatic arterial yttrium 90 microspheres: another treatment option for hepatocellular carcinoma J Vasc Interv Radiol 16 2005 161 164 (Pubitemid 40326273)
11. L.A. Dawson The evolving role of radiation therapy in hepatocellular carcinoma Cancer Radiother 12 2008 96 101
12. T.W. Leung Non-surgical management A.S.Y. Leong, C.T. Liew, J.W.Y. Lau, P.J. Johnson, Hepatocellular carcinoma 1999 Arnold London 173 192
13. R. Salem, K.G. Thurston, and B.I. Carr Yttrium-90 microspheres: Radiation therapy for unresectable liver cancer J Vasc Interv Radiol 13 2002 S223 S229
14. How to review the evidence Systematic identification and review of the scientific literature. Canberra Australia: National Health and Medical Research Council;2000 National Health and Medical Research Council 2000 Australia Canberra
15. S. Ho, W.Y. Lau, and T.W. Leung Internal radiation therapy for patients with primary or metastatic hepatic cancer: A review Cancer 83 1998 1894 1907 (Pubitemid 28503720)
16. S. Ho, P.J. Johnson, and W.T. Leung Combating hepatocellular carcinoma with an integrated approach Chin Med J (Engl) 112 1999 80 83 (Pubitemid 29061617)
17. S. Ho, J.W. Lau, and T.W. Leung Intrahepatic (90)Y-microspheres for hepatocellular carcinoma J Nucl Med 42 2001 1587 1589
18. ® Yttrium-90 Glass Microspheres US Package Insert. Ottawa, Canada.
19. R. Salem, and K.G. Thurston Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations J Vasc Interv Radiol 17 2006 1251 1278 (Pubitemid 44259009)
20. ® Microspheres Package Insert. Sydney, Australia.
21. W.Y. Lau, T.W. Leung, and S. Ho Diagnostic pharmaco-scintigraphy with hepatic intra-arterial technetium-99m macroaggregated albumin in the determination of tumour to non-tumour uptake ratio in hepatocellular carcinoma Br J Radiol 67 1994 136 139 (Pubitemid 24054366)
22. S. Ho, W.Y. Lau, and T.W. Leung Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours Eur J Nucl Med 23 1996 947 952 (Pubitemid 26278795)
23. S. Ho, W.Y. Lau, and T.W. Leung Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer Eur J Nucl Med 24 1997 293 298 (Pubitemid 27165858)
24. S. Ho, W.Y. Lau, and T.W. Leung Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin Br J Radiol 70 1997 823 828 (Pubitemid 27373117)
25. S. Ho, W.Y. Lau, and W.T. Leung Arteriovenous shunts in patients with hepatic tumors J Nucl Med 38 1997 1201 1205 (Pubitemid 27332612)
26. T.W. Leung, W.Y. Lau, and S.K. Ho Determination of tumour vascularity using selective hepatic angiography as compared with intrahepatic-arterial technetium-99m macroaggregated albumin scan in hepatocellular carcinoma Cancer Chemother Pharmacol 33 1994 S33 S36
27. R. Salem, R.J. Lewandowski, and K.T. Sato Technical aspects of radioembolization with 90Y microspheres Tech Vasc Interv Radiol 10 2007 12 29 (Pubitemid 350008084)
28. T.W. Leung, W.Y. Lau, and S.K. Ho Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin J Nucl Med 35 1994 70 73 (Pubitemid 24018443)
29. T.W. Leung, W.Y. Lau, and S.K. Ho Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors Int J Radiat Oncol Biol Phys 33 1995 919 924
30. J.E. Goin, R. Salem, and B.I. Carr Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: Factors associated with liver toxicities J Vasc Interv Radiol 16 2005 205 213 (Pubitemid 40322293)
31. J.E. Goin, R. Salem, and B.I. Carr Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: A risk-stratification analysis J Vasc Interv Radiol 16 2005 195 203 (Pubitemid 40322292)
32. J.Y. Young, T.K. Rhee, and B. Atassi Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma J Vasc Interv Radiol 18 2007 1375 1382 (Pubitemid 47628904)
33. R. Salem, P. Parikh, and B. Atassi Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution Am J Clin Oncol 31 2008 431 438
34. B. Sangro, B. Gil-Alzugaray, and J. Rodriguez Liver disease induced by radioembolization of liver tumors: Description and possible risk factors Cancer 112 2008 1538 1546 (Pubitemid 351441166)
35. R. Neff, R. Abdel-Misih, and J. Khatri The toxicity of liver directed yttrium-90 microspheres in primary and metastatic liver tumors Cancer Invest 26 2008 173 177 (Pubitemid 351225466)
36. T.F. Jakobs, S. Saleem, and B. Atassi Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90yttrium microspheres Dig Dis Sci 53 2008 2556 2563
37. B. Atassi, A.K. Bangash, and R.J. Lewandowski Biliary sequelae following radioembolization with Yttrium-90 microspheres J Vasc Interv Radiol 19 2008 691 697
38. C.D. South, M.M. Meyer, and G. Meis Yttrium-90 microsphere induced gastrointestinal tract ulceration World J Surg Oncol 6 2008 93
39. M.A. Nalesnik, M. Federle, and D. Buck Hepatobiliary effects of 90yttrium microsphere therapy for unresectable hepatocellular carcinoma Hum Pathol 40 2009 125 134
40. R. Rühl, M. Seidensticker, and N. Peters Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy Dig Dis 27 2009 189 199
41. W.Y. Lau, W.T. Leung, and S. Ho Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: A Phase I and II study Br J Cancer 70 1994 994 999 (Pubitemid 24331102)
42. W.Y. Lau, S. Ho, and T.W. Leung Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres Int J Radiat Oncol Biol Phys 40 1998 583 592 (Pubitemid 28104228)
43. J.E. Dancey, F.A. Shepherd, and K. Paul Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres J Nucl Med 41 2000 1673 1681
44. B.I. Carr Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: Interim safety and survival data on 65 patients Liver Transpl 10 2004 S107 S110
45. J.F. Geschwind, R. Salem, and B.I. Carr Yttrium-90 microspheres for the treatment of hepatocellular carcinoma Gastroenterology 127 2004 S194 S205
46. M.D. Liu, M.B. Uaje, and M.S. Al-Ghazi Use of yttrium-90 TheraSphere for the treatment of unresectable hepatocellular carcinoma Am Surg 70 2004 947 953
47. B. Sangro, J.I. Bilbao, and J. Boan Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma Int J Radiat Oncol Biol Phys 66 2006 792 800 (Pubitemid 44436697)
48. R. Salem, R.J. Lewandowski, and B. Atassi Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): Safety, tumor response, and survival J Vasc Interv Radiol 16 2005 1627 1639 (Pubitemid 44431160)
49. R. Salem, R.J. Lewandowski, and M.F. Mulcahy Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: A comprehensive report of long-term outcomes Gastroenterology 138 2010 52 64
50. G.H. Keng, F.X. Sundram, and S.W. Yu Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates Ann Acad Med Singapore 31 2002 382-326
51. F.A. Shepherd, L.E. Rotstein, and S. Houle A Phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma Cancer 70 1992 2250 2254
52. S. Houle, T.K. Yip, and F.A. Shepherd Hepatocellular carcinoma: Pilot trial of treatment with Y-90 microspheres Radiology 172 1989 857 860 (Pubitemid 19211619)
53. J.C. Andrews, S.C. Walker, and R.J. Ackermann Hepatic radioembolization with yttrium-90 containing glass microspheres: Preliminary results and clinical follow-up J Nucl Med 35 1994 1637 1644
54. P.L. Roberson, R.K. Ten Haken, and D.L. McShan Three-dimensional tumor dosimetry for hepatic yttrium-90-microsphere therapy J Nucl Med 33 1992 735 738
55. V. Gates, M.M. Abecassis, and R.A. Omary Radiation lobectomy: Preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization Ann Surg Oncol 16 2009 1587 1596
56. R. Salem, R. Lewandowski, and C. Roberts Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis J Vasc Interv Radiol 15 2004 335 345 (Pubitemid 38451976)
57. L.M. Kulik, B.I. Carr, and M.F. Mulcahy Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis Hepatology 47 2008 71 81 (Pubitemid 351171043)
58. C.E. Woodall, C.R. Scoggins, and S.F. Ellis Is selective internal radioembolization safe and effective for patients with inoperable hepatocellular carcinoma and venous thrombosis? J Am Coll Surg 208 2009 375 382
59. A. Kennedy, S. Nag, and R. Salem Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: A consensus panel report from the radioembolization brachytherapy oncology consortium Int J Radiat Oncol Biol Phys 68 2007 13 23 (Pubitemid 46589861)
60. W.Y. Lau, S. Ho, and W.T. Leung What determines survival duration in hepatocellular carcinoma treated with intraarterial Yttrium-90 microspheres? Hepatogastroenterology 48 2001 338 340 (Pubitemid 32391562)
61. V. Mazzaferro, E. Regalia, and R. Doci Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699 (Pubitemid 26079803)
62. J. Figueras, L. Ibanez, and E. Ramos Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: Results of a multicenter study Liver Transpl 7 2001 877 883 (Pubitemid 33040462)
63. J.M. Llovet, J. Fuster, and J. Bruix Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation Hepatology 30 1999 1434 1440
64. F.Y. Yao, L. Ferrell, and N.M. Bass Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival Hepatology 33 2001 1394 1403 (Pubitemid 32496976)
65. J.P. Duffy, A. Vardanian, and E. Benjamin Liver transplantation criteria for hepatocellular carcinoma should be expanded: A 22-year experience with 467 patients at UCLA Ann Surg 246 2007 502 511
66. Y.K. Maddala, L. Stadheim, and J.C. Andrews Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: Outcome with chemoembolization Liver Transpl 10 2004 449 455 (Pubitemid 38380323)
67. F.Y. Yao, N.M. Bass, and N.L. Ascher Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy Liver Transpl 10 2004 621 630 (Pubitemid 38628222)
68. J.T. Heckman, M.B. Devera, and J.W. Marsh Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation Ann Surg Oncol 15 2008 3169 3177
69. W.Y. Lau, and E.C. Lai Salvage surgery following downstaging of unresectable hepatocellular carcinoma - a strategy to increase resectability Ann Surg Oncol 14 2007 3301 3309 (Pubitemid 350160117)
70. G.C. Sotiropoulos, P. Hilgard, and G. Antoch Liver transplantation for hepatocellular carcinoma after yttrium therapy: A case report Transplant Proc 40 2008 3804 3805
71. D.Y. Kim, D.S. Kwon, and R. Salem Successful embolization of hepatocelluar carcinoma with yttrium-90 glass microspheres prior to liver transplantation J Gastrointest Surg 10 2006 413 416 (Pubitemid 43303837)
72. L.M. Kulik, M.F. Mulcahy, and R.D. Hunter Use of yttrium-90 microspheres (TheraSphere) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: A case report Liver Transpl 11 2005 1127 1131 (Pubitemid 41341764)
73. W.Y. Lau, T.W. Leung, and B.S. Lai Preoperative systemic chemoimmunotherapy and sequential resection for unresectable hepatocellular carcinoma Ann Surg 233 2001 236 2341
74. W.Y. Lau, S.K. Ho, and S.C. Yu Salvage surgery following downstaging of unresectable hepatocellular carcinoma Ann Surg 240 2004 299 305 (Pubitemid 38963022)
75. L.M. Kulik, B. Atassi, and L. van Holsbeeck Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantation J Surg Oncol 94 2006 572 586 (Pubitemid 44851918)
76. R.J. Lewandowski, L.M. Kulik, and A. Riaz A comparative analysis of transarterial downstaging for hepatocellular carcinoma: Chemoembolization versus radioembolization Am J Transpl 9 2009 1920 1928
77. L. Rivera, H. Giap, and W. Miller Hepatic intra-arterial infusion of yttrium-90 microspheres in the treatment of recurrent hepatocellular carcinoma after liver transplantation: A case report World J Gastroenterol 12 2006 5729 5732 (Pubitemid 44594053)